BIOVICA
LIVE

Serial Number

97384814

Owner

Biovica International AB

Attorney

Mark H. Tidman

First Use Date

Mar 24, 2023

Filing Date

Apr 27, 2022

Add to watchlist:

No watchlists yet
View on USPTO

BIOVICA Trademark

Serial Number: 97384814 • Registration: 7689670

BIOVICA is a trademark filed by Biovica International AB on April 27, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Biovica International AB (3 trademarks)

Dag Hammarskjölds väg 54B

Entity Type: 99

Trademark Details

Filing Date

April 27, 2022

Registration Date

February 11, 2025

First Use Anywhere

March 24, 2023

First Use in Commerce

March 24, 2023

Published for Opposition

November 14, 2023

Goods & Services

(Based on 44(e)) Diagnostic agents and reagents, preparations and substances for medical and veterinary purposes for the measurement of cell division; diagnostic agents and reagents, preparations and substances for measuring enzyme activity for medical and veterinary purposes; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in cancer therapy; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in viral diseases; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in autoimmune diseases

(Based on Use in Commerce) Diagnostic preparations for scientific or research use; diagnostic agents and reagents for scientific or research use

(Based on 44(e)) Medical, biomedical and veterinary diagnostic monitoring and testing services regarding blood serum or plasma samples or cell cultures; medical, biomedical and veterinary diagnostic monitoring and testing services regarding measurement of cell proliferation; medical, biomedical and veterinary diagnostic monitoring and testing services regarding measurement of enzymatic activity; provision of medical information and advice relating to the use of medical and veterinary diagnostic equipment; medical testing for diagnostic or treatment purposes, namely, conducting tests to identify diseases affecting cell division, cancer, viral and autoimmune diseases; medical analysis regarding the identification and monitoring of cancer, virus and autoimmune diseases and other diseases that cause cell growth for the diagnosis and treatment of persons

(Based on 44(e)) Scientific laboratory services and scientific research and analysis regarding monitoring and predicting treatment response to cancer therapy, and in viral therapy and autoimmune therapy; scientific laboratory services and research and analysis regarding measuring the activity of enzyme in blood serum or cell cultures; research and development in the field of diagnostic preparations; scientific research and development, namely, diagnostic development; data science services, namely, compiling data for research purposes in the field of biostatistics; laboratory biomarker analysis services and related data analysis; biochemical analysis; medical laboratory services; conducting preclinical studies in the nature of scientific feasibility studies; medical laboratory services regarding measurement of cell division; conducting scientific feasibility studies, namely, preclinical studies regarding measurement of cell proliferation; medical laboratory services regarding measurement of enzymatic activity; conducting scientific feasibility studies, namely, preclinical studies regarding measurement of enzymatic activity

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 11, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 11, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 23, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 23, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Aug 2, 2024 SUPC
USE AMENDMENT FILED
Jul 3, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 3, 2024 EISU
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 3, 2024 CHAN
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 3, 2024 AITU
TEAS DELETE 1(B) BASIS RECEIVED
Feb 21, 2024 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 9, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 14, 2023 NPUB
PUBLISHED FOR OPPOSITION
Nov 14, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 25, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 11, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 11, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 11, 2023 CRFA
ASSIGNED TO LIE
Jul 10, 2023 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 8, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 2, 2023 GNRN
NON-FINAL ACTION E-MAILED
Feb 2, 2023 GNRT
NON-FINAL ACTION WRITTEN
Feb 2, 2023 CNRT
ASSIGNED TO EXAMINER
Jan 31, 2023 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 10, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 10, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 10, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 10, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 10, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 10, 2022 COAR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 3, 2022 NWOS
NEW APPLICATION ENTERED
Apr 30, 2022 NWAP